Monthly Archives: April 2016

Betahistine in treating Meniere’s disease patients

What is the long term efficacy of betahistine dihydrochloride on the incidence of vertigo attacks in patients with Meniere’s disease, compared with placebo?

METHODS:
The BEMED trial is a multicentre, double blind, randomised, placebo controlled, three arm, parallel group, phase III, dose defining superiority trial conducted in 14 German tertiary referral centres

Results of this interesting study you can find HERE